Allogene Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking
Allogene Therapeutics, Inc. Company Intro
A clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer.
Allogene Therapeutics, Inc. Headquaters
210 East Grand Avenue
South San Francisco,94080 United States